The experimental new treatment, being developed by researchers from the Moscow-based Russian National Research Medical University, has been successfully tested on cancer-afflicted lab mice, showing a nearly 70% increase in the animals’ lifespan. The drug consists of magnetite nanoparticles laced with a toxic cytostatic agent, which attacks and destroys tumor cells.